tradingkey.logo

SelectQuote Inc

SLQT
1.100USD
+0.070+6.80%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
193.90MCap. mercado
10.13P/E TTM

SelectQuote Inc

1.100
+0.070+6.80%

Más Datos de SelectQuote Inc Compañía

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Información de SelectQuote Inc

Símbolo de cotizaciónSLQT
Nombre de la empresaSelectQuote Inc
Fecha de salida a bolsaMay 21, 2020
Director ejecutivoDanker (Timothy Robert)
Número de empleados1181
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 21
Dirección6800 West 115Th Street
CiudadOVERLAND PARK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal66211
Teléfono19132741994
Sitio Webhttps://ir.selectquote.com/investor-home/default.aspx
Símbolo de cotizaciónSLQT
Fecha de salida a bolsaMay 21, 2020
Director ejecutivoDanker (Timothy Robert)

Ejecutivos de SelectQuote Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%
Mr. Donald L. Hawks, III
Mr. Donald L. Hawks, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Earl H. (Trace) Devanny, III
Mr. Earl H. (Trace) Devanny, III
Independent Director
Independent Director
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
328.81M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Otro
72.17%
Accionistas
Accionistas
Proporción
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Otro
72.17%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
20.37%
Investment Advisor/Hedge Fund
12.09%
Individual Investor
11.43%
Private Equity
10.03%
Hedge Fund
8.15%
Research Firm
2.10%
Corporation
0.62%
Pension Fund
0.28%
Bank and Trust
0.21%
Otro
34.72%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
334
93.80M
53.31%
-7.75M
2025Q3
327
94.38M
53.63%
-3.32M
2025Q2
332
110.44M
63.96%
+4.81M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.01M
5.12%
-200.07K
-2.17%
Sep 30, 2025
The Vanguard Group, Inc.
8.19M
4.65%
-20.74K
-0.25%
Sep 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Sep 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+3.06K
+0.05%
Sep 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.33M
1.89%
+29.89K
+0.91%
Sep 30, 2025
State Street Investment Management (US)
2.96M
1.68%
-139.64K
-4.50%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
WisdomTree US SmallCap Quality Growth Fund
0.04%
Avantis US Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Ver más
iShares Micro-Cap ETF
Proporción0.06%
Fidelity Enhanced Small Cap ETF
Proporción0.04%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.04%
Avantis US Small Cap Equity ETF
Proporción0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.02%
ProShares Hedge Replication ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Avantis US Small Cap Value ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI